Total Funding
78
20
Total FundingVenture - Series Unknown raised
Growth Score 78 in past quarter
-10 pts
Heat Score 20 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
782484
Altacor develops ophthalmic products for ophthalmologists and patients.
Acquired by 
Fidia Farmaceutici
Stephane Mery: Non-Executive DirectorPast Role: Community Pharmacy, Director
About the Company
Altacor develops and brings to market specialist ophthalmic products designed for the needs of both ophthalmologists and patients.
Altacor brings together skills in drug development with in-depth market knowledge and an understanding of the European regulatory environment, to create a portfolio of high quality, differentiated prescription
medicines that set new standards in the sector.
Altacor's pipeline includes products for dry-eye, glaucoma, glaucoma surgery and ocular surgery.
